TRANS GENIC INC. is a company engaged in the biotechnology business. The Company operates in four business segments. The Genomics segment is engaged in the licensing of genetic information, the manufacturing contract of genetic knockout mice, and the gene analysis contract business, among others. The Contract Research Organization (CRO) segment is engaged in the clinical trials of medicines and food, and others. The Antibody Reagent segment is engaged in the development of new biomarkers, the sale of research reagents, and the provision of drug discovery support services for individualized medicine, among others. The Pathological Diagnosis segment is engaged in the provision of pathological diagnosis services. As of March 31, 2014, the Company had four subsidiaries and one associated company.